NO20062409L - Fremgangsmater for a administrere vann-loselige prodrug av propofol for forlenget beroligene virkning - Google Patents
Fremgangsmater for a administrere vann-loselige prodrug av propofol for forlenget beroligene virkningInfo
- Publication number
- NO20062409L NO20062409L NO20062409A NO20062409A NO20062409L NO 20062409 L NO20062409 L NO 20062409L NO 20062409 A NO20062409 A NO 20062409A NO 20062409 A NO20062409 A NO 20062409A NO 20062409 L NO20062409 L NO 20062409L
- Authority
- NO
- Norway
- Prior art keywords
- propofol
- prolonged
- methods
- prodrug
- soothing effect
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/091—Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Physical Education & Sports Medicine (AREA)
- Biochemistry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Dermatology (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US53014903P | 2003-12-17 | 2003-12-17 | |
| US55399104P | 2004-03-17 | 2004-03-17 | |
| US62295404P | 2004-10-28 | 2004-10-28 | |
| PCT/US2004/042301 WO2005058250A2 (en) | 2003-12-17 | 2004-12-17 | Methods of administering water-soluble prodrugs of propofol for extended sedation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20062409L true NO20062409L (no) | 2006-09-18 |
Family
ID=34705104
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20062409A NO20062409L (no) | 2003-12-17 | 2006-05-26 | Fremgangsmater for a administrere vann-loselige prodrug av propofol for forlenget beroligene virkning |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20070202158A1 (pt) |
| EP (1) | EP1694277A2 (pt) |
| JP (1) | JP2007524661A (pt) |
| KR (1) | KR20060124619A (pt) |
| AU (1) | AU2004299109A1 (pt) |
| BR (1) | BRPI0417472A (pt) |
| CA (1) | CA2548216A1 (pt) |
| IL (1) | IL175913A0 (pt) |
| NO (1) | NO20062409L (pt) |
| WO (1) | WO2005058250A2 (pt) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060198891A1 (en) | 2004-11-29 | 2006-09-07 | Francois Ravenelle | Solid formulations of liquid biologically active agents |
| KR20090059136A (ko) * | 2006-10-05 | 2009-06-10 | 에이자이 코포레이션 오브 노쓰아메리카 | 프로포폴의 수용성 프로드럭의 수성 약제학적 제제 |
| WO2008157627A1 (en) * | 2007-06-21 | 2008-12-24 | Xenoport, Inc. | Use of propofol prodrugs for treating alcohol withdrawal, central pain, anxiety or pruritus |
| US20090076141A1 (en) * | 2007-09-14 | 2009-03-19 | Xenoport, Inc. | Use of Propofol Prodrugs for Treating Neuropathic Pain |
| US20090098209A1 (en) * | 2007-10-15 | 2009-04-16 | University Of Kansas | Pharmaceutical compositions containing water-soluble derivatives of propofol and methods of administering same via pulmonary administration |
| GB0905834D0 (en) | 2009-04-03 | 2009-05-20 | Seps Pharma Nv | Phosphonyl-containing phenolic derivatives useful as medicaments |
| WO2011130834A1 (en) * | 2010-04-23 | 2011-10-27 | Labopharm Inc. | Non-intravenous dosage form comprising solid formulation of liquid biologically active agent and uses thereof |
| US11331271B2 (en) | 2016-05-27 | 2022-05-17 | The Johns Hopkins University | Buccal, sublingual and intranasal delivery of fospropofol |
| US11478490B1 (en) | 2021-03-30 | 2022-10-25 | Epalex Corporation | Fospropofol formulations |
| US11628178B2 (en) | 2019-03-26 | 2023-04-18 | Epalex Corporation | Fospropofol methods and compositions |
| US11439653B1 (en) | 2021-03-30 | 2022-09-13 | Epalex Corporation | Fospropofol formulations |
| US11547714B2 (en) | 2020-02-05 | 2023-01-10 | Epalex Corporation | Fospropofol salts, methods and compositions |
| WO2024108501A1 (zh) * | 2022-11-24 | 2024-05-30 | 中国科学院深圳先进技术研究院 | 丙泊酚的抗焦虑制药用途及抗焦虑药物制剂 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6204257B1 (en) * | 1998-08-07 | 2001-03-20 | Universtiy Of Kansas | Water soluble prodrugs of hindered alcohols |
| US6362234B1 (en) * | 2000-08-15 | 2002-03-26 | Vyrex Corporation | Water-soluble prodrugs of propofol for treatment of migrane |
-
2004
- 2004-12-17 BR BRPI0417472-0A patent/BRPI0417472A/pt not_active Application Discontinuation
- 2004-12-17 WO PCT/US2004/042301 patent/WO2005058250A2/en not_active Ceased
- 2004-12-17 AU AU2004299109A patent/AU2004299109A1/en not_active Abandoned
- 2004-12-17 EP EP04814480A patent/EP1694277A2/en not_active Withdrawn
- 2004-12-17 JP JP2006545440A patent/JP2007524661A/ja active Pending
- 2004-12-17 CA CA002548216A patent/CA2548216A1/en not_active Abandoned
- 2004-12-17 KR KR1020067011443A patent/KR20060124619A/ko not_active Withdrawn
- 2004-12-17 US US10/580,405 patent/US20070202158A1/en not_active Abandoned
-
2006
- 2006-05-25 IL IL175913A patent/IL175913A0/en unknown
- 2006-05-26 NO NO20062409A patent/NO20062409L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1694277A2 (en) | 2006-08-30 |
| AU2004299109A1 (en) | 2005-06-30 |
| JP2007524661A (ja) | 2007-08-30 |
| CA2548216A1 (en) | 2005-06-30 |
| BRPI0417472A (pt) | 2007-05-08 |
| WO2005058250A3 (en) | 2007-03-22 |
| KR20060124619A (ko) | 2006-12-05 |
| WO2005058250A2 (en) | 2005-06-30 |
| IL175913A0 (en) | 2006-10-05 |
| US20070202158A1 (en) | 2007-08-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20062409L (no) | Fremgangsmater for a administrere vann-loselige prodrug av propofol for forlenget beroligene virkning | |
| DK1567164T3 (da) | Anvendelse af loxapin til fremstilling af et lægemiddel til behandling af smerte | |
| EG25822A (en) | Quinolinyl-pyrrolopyrazoles | |
| HUP9801283A2 (hu) | Tomoxetin alkalmazása figyelemhiány/hiperaktivitás betegség kezelésére alkalmas gyógyszerkészítmény előállítására | |
| NO20030365L (no) | Fentanylpreparat for nasal administrering | |
| DK1458388T3 (da) | En flydende farmaceutisk formulering omfattende nikotin til administrering i mundhulen | |
| BR9916224A (pt) | Forma de dosagem farmacêutica oral, processos para a manufatura de uma forma de dosagem fixa, para o tratamento e a profilaxia de distúrbios gastrintestinais e para evitar efeitos colaterias gastrintestinais, uso de uma forma de dosagem, combinação, e, embalagem tipo ampola | |
| PL2043637T3 (pl) | Sposoby i leki do podawania ibuprofenu | |
| CY1108401T1 (el) | Παραγωγα πυρρολοϊμιδαζολης, η παρασκευη τους, φαρμακευτικες συνθεσεις που τα περιεχουν και η χρηση τους ως νοοτροπικων παραγοντων | |
| EP2281565A3 (en) | Pharmaceutical compositions containing water-soluble prodrugs of propofol and methods of administering same | |
| UA88792C2 (ru) | Гидроксибензоатные соли метаникотиновых соединений | |
| AR030039A1 (es) | Composicion farmaceutica que comprende una droga inhibidora selectiva de la ciclooxigenasa-2, su uso en la fabricacion de un medicamento para tratar o prevenir afecciones mediadas por la ciclooxigenasa-2 y metodo para hacer dicho medicamento | |
| DK1261333T3 (da) | Anvendelse af topiramate for behandling og diagnosticering af sövnbesværet vejrtrækning og midler for udförsel af behandlingen og diagnosticeringen | |
| NO308644B1 (no) | Anvendelse av 4-aminopyridin for fremstilling av et farmasøytisk preparat | |
| NO20064642L (no) | Anvendelse av (S,S)- eller racemisk reboxetin | |
| NO20050771L (no) | Bicifadinformulering | |
| WO2006033911A3 (en) | Methods of administering water-soluble prodrugs of propofol | |
| BRPI0417117A (pt) | temozolomida cristalizada, processo de preparação de temozolomida cristalizada, composição farmacêutica, método de produção de medicamento contendo temozolomida e método de tratamento de uma condição médica para a qual a termozolomida é benéfica | |
| CA2125477A1 (en) | Therapeutic methods using caesium ions | |
| MD2327G2 (ro) | Metodă de tratament al afecţiunilor parodonţiului | |
| CN106668039A (zh) | 一种治疗神经衰弱的药物组合物 | |
| IS6017A (is) | Aðferð til meðhöndlunar á höfuðverk | |
| RU2007115764A (ru) | Способ лечения хронического helicobacter pylori - ассоциированного гастрита культи желудка | |
| Come | ALTERNATIVE THERAPIES | |
| Kamming et al. | Day surgery analgesia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |